| Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis. | 2023 | Frontiers in Cardiovascular Medicine |
| Prophylactic efficacy and safety of antithrombotic regimens in patients with stable atherosclerotic cardiovascular disease (S-ASCVD): A bayesian network meta-regression analysis. | 2023 | American Journal of Cardiovascular Drugs |
| Antithrombotic regimens for the prevention of major adverse cardiac events in chronic coronary syndrome: A systematic review and network meta-analysis. | 2023 | Frontiers in Cardiovascular Medicine |
| A comparison of antiplatelet therapy during the peri- and post-operative periods following flow-diverting stent insertion for unruptured intracranial aneurysms: A systematic review. | 2023 | Interventional Neuroradiology |
| Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials. | 2023 | Frontiers in Cardiovascular Medicine |
| Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials. | 2023 | Perfusion |
| Safety and efficacy of ticagrelor versus clopidogrel in east asian patients with acute coronary syndrome undergoing percutaneous coronary intervention treated with dual antiplatelet therapy: A meta-analysis of randomized controlled trials. | 2023 | Cardiology |
| Efficacy and Safety of Ticagrelor versus Aspirin and Clopidogrel for Stroke Prevention in Patients with Vascular Disease: A Systematic Review and Meta-Analysis. | 2023 | European Neurology |
| Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials. | 2023 | Frontiers in Cardiovascular Medicine |
| P2Y12 Inhibitors for Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis. | 2023 | The Texas Heart Institute Journal |
| Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trials. | 2023 | Journal of Cardiology |
| Efficacy and Safety of Ticagrelor versus Clopidogrel in Dialysis Patients with Coronary Syndromes: A Systematic Review and Meta-Analysis. | 2023 | Journal of Clinical Medicine |
| Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. | 2023 | Circulation: Cardiovascular Interventions |
| Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis. | 2023 | Cardiovascular Therapeutics |
| The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis. | 2023 | PLoS One |
| Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. | 2023 | The American Journal of Cardiology |
| Efficacy and safety of de-escalation of antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome: A meta-analysis of randomized clinical trials. | 2022 | Journal of Cardiovascular Pharmacology |
| Efficacy and safety of clopidogrel versus ticagrelor as part of dual antiplatelet therapy in acute coronary syndrome - a systematic review and meta-analysis. | 2022 | Journal of Cardiovascular Pharmacology |
| Comparison of clinical outcomes between ticagrelor and clopidogrel in acute coronary syndrome: A comprehensive meta-analysis. | 2022 | Frontiers in Cardiovascular Medicine |
| Comparison of prasugrel and ticagrelor for patients with acute coronary syndrome: A systematic review and meta-analysis. | 2022 | Cardiology |
| Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: A systematic review with qualitative and quantitative meta-analysis. | 2022 | BMC Cardiovascular disorders |
| Comparison of ticagrelor with clopidogrel in East Asian patients with acute coronary syndrome: A systematic review and meta-analysis of randomized clinical trials. | 2022 | Journal of Cardiovascular Pharmacology |
| P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis. | 2022 | European Journal of Internal Medicine |
| Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis. | 2022 | Frigid Zone Medicine |
| Acute coronary syndrome and renal impairment: A systematic review. | 2022 | Reviews in Cardiovascular Medicine |
| Dual Antiplatelet Therapy in Patients Aged 75 Years and Older with Coronary Artery Disease: A Meta-Analysis and Systematic Review. | 2022 | Journal of Interventional Cardiology |
| P2Y12 receptor inhibitor plus aspirin versus aspirin treated within 24 hours of acute noncardioembolic ischemic stroke or TIA: Meta-analysis. | 2022 | Journal of the Formosan Medical Association |
| Early vs. delayed initiation of treatment with P2Y12 inhibitors in patients with non-ST-segment elevation acute coronary syndrome: A systematic review and network meta-analysis of randomized controlled trials. | 2022 | Frontiers in Cardiovascular Medicine |
| Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials. | 2022 | Frontiers in Pharmacology |
| Effect of ticagrelor monotherapy on mortality after percutaneous coronary intervention: A systematic review and meta-analysis of randomized trials including 26 143 patients. | 2022 | European Heart Journal - Cardiovascular Pharmacotherapy |
| Newer P2Y12 Inhibitors vs Clopidogrel in Acute Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock: A Systematic Review and Meta-analysis. | 2022 | Mayo Clinic Proceedings |
| Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. | 2022 | Drugs |
| Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis . | 2022 | Circulation: Cardiovascular Interventions |
| Impact of prasugrel and ticagrelor on platelet reactivity in patients with acute coronary syndrome: A meta-analysis. | 2022 | Frontiers in Cardiovascular Medicine |
| Efficacy of ticagrelor compared to clopidogrel in improving endothelial function in patients with coronary artery disease: A systematic review. | 2022 | Journal of Cardiovascular Medicine |
| Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials. | 2022 | PLoS One |
| Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. | 2021 | Current Vascular Pharmacology |
| Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: A meta-analysis. | 2021 | Vascular Pharmacology |
| Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: A systematic review and meta-analysis of randomized clinical trials. | 2021 | European Heart Journal |
| Effect of CYP2C19 genotype on ischemic outcomes during oral P2Y12 inhibitor therapy: A meta-analysis. | 2021 | JACC: Cardiovascular Interventions |
| De-escalation of dual antiplatelet therapy in patients with acute coronary syndromes. | 2021 | Journal of the American College of Cardiology |
| Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis. | 2021 | The Lancet |
| Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: A systematic review and network meta-analysis. | 2021 | BMC Neurology |
| Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: Systematic review and meta-analysis of randomized controlled clinical trials. | 2021 | Circulation |
| Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: A systematic review and network meta-analysis. | 2021 | Annals of Translational Medicine |
| Comparison of major bleeding in patients with acute coronary syndrome that underwent coronary artery bypass grafting treated with clopidogrel or ticagrelor: A systematic review and meta-analysis. | 2021 | F1000Research |
| Efficacy and safety of ticagrelor monotherapy in patients following percutaneous coronary intervention. | 2021 | Medicine |
| Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials. | 2021 | Vascular Pharmacology |
| Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis. | 2021 | Clinical Cardiology |
| Potent P2Y12 inhibitors versus Clopidogrel in elderly patients with acute coronary syndrome: Systematic review and meta-analysis. | 2021 | American Heart Journal |
| Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. | 2021 | Journal of Cardiovascular Pharmacology |
| Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2021 | Journal of Cardiovascular Development and Disease |
| Comparison of Safety and Efficacy Between Clopidogrel and Ticagrelor in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. | 2021 | Frontiers in Pharmacology |
| Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: A systematic review and meta-analysis. | 2020 | Postgraduate Medical Journal |
| Prasugrel vs ticagrelor for DAPT in patients with ACS undergoing PCI: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Cardiovascular Revascularization Medicine |
| Ticagrelor for the primary prevention of stroke in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Journal of Thrombosis and Thrombolysis |
| Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis. | 2020 | Pharmacological Research |
| Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: A meta-analysis. | 2020 | BMC Cardiovascular Disorders |
| Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized trials. | 2020 | Cardiovascular Drugs and Therapy |
| The risk of dyspnea in patients treated with third-generation P2Y12 inhibitors compared with clopidogrel: A meta-analysis of randomized controlled trials. | 2020 | BMC Cardiovascular Disorders |
| P2Y 12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: A systematic review and meta-analysis. | 2020 | Heart |
| Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: A network meta‑analysis. | 2020 | Scientific Reports |
| Ticagrelor for Asian patients with acute coronary syndrome in real-world practice: A systematic review and meta-analysis of observational studies. | 2019 | Indian Heart Journal |
| Is there Sex-related Outcome Difference According to oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients. | 2019 | Current Vascular Pharmacology |
| Efficacy and safety of ticagrelor compared to clopidogrel in patients undergoing percutaneous coronary intervention: A meta-analysis. | 2019 | Current Pharmaceutical Design |
| Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: A comprehensive meta-analysis. | 2019 | Drug Design, Development and Therapy |
| Prasugrel vs. ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: a systematic review and meta‑analysis. | 2019 | American Journal of Cardiovascular Drugs |
| Effect of Pre-Hospital Ticagrelor in Primary Percutaneous Coronary Intervention on Patients with ST-Segment Elevation Myocardial Infarction: A systematic review and meta-analysis. | 2019 | The Journal of Pakistan Medical Association |
